Answers are grounded in this paper and cite their sources.
Multi-cohort genetic study reveals cytotoxic CD161−CD8+ TEMRA cell expansion in systemic lupus erythematosus, highlighting potential therapeutic targets.
Background Systemic lupus erythematosus (SLE) is a prototypical autoimmune disease affecting multiple organs and tissues with high cellular heterogeneity.CD8 + T cell activity is involved in the SLE pathogenesis.However, the cellular heterogeneity and the underlying mechanisms of CD8 + T cells in SLE remain to be identified.Methods Single-cell RNA sequencing (scRNA-seq) of PBMCs from a SLE family pedigree (including 3 HCs and 2 SLE patients) was performed to identify the SLE-associated CD8 + T cell subsets.Flow cytometry analysis of a SLE cohort (including 23 HCs and 33 SLE patients), qPCR analysis of another SLE cohort (including 30 HCs and 25 SLE patients) and public scRNA-seq datasets of autoimmune diseases were employed to validate the finding.Whole-exome sequencing (WES) of this SLE family pedigree was used to investigate the genetic basis in dysregulation of CD8 + T cell subsets identified in this study.Co-culture experiments were performed to analyze the activity of CD8 + T cells.Findings We elucidated the cellular heterogeneity of SLE and identified a new highly cytotoxic CD8 + T cell subset, CD161 -CD8 + T EMRA cell subpopulation, which was remarkably increased in SLE patients.Meanwhile, we discovered a close correlation between mutation of DTHD1 and the abnormal accumulation of CD161 -CD8 + T EMRA cells in SLE.DTHD1 interacted with MYD88 to suppress its activity in T cells and DTHD1 mutation promoted MYD88-dependent pathway and subsequently increased the proliferation and cytotoxicity of CD161 -CD8 + T EMRA cells.Furthermore, the differentially expressed genes in CD161 -CD8 + T EMRA cells displayed a strong out-of-sample prediction for casecontrol status of SLE.Interpretation This study identified DTHD1-associated expansion of CD161 -CD8 + T EMRA cell subpopulation is critical for SLE.Our study highlights genetic association and cellular heterogeneity of SLE pathogenesis and provides a mechanistical insight into the diagnosis and treatment of SLE.
No takes yet. Share an insight, caveat, or question.
Xiong et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: